Premium Information is available for this item - Upgrade for $1 a day
6515-01-482-9393
Cornea Collagen Shield
6515014829393 014829393 7012
INC: 77777
January 2023
1
Marketplace 6515-01-482-9393
Request a Quotation from participating marketplace vendors
Related Documents 6515-01-482-9393 2+ Documents (More...)
Documents 6515-01-482-9393 1+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6515/us 6515
Updated Every Day 6515-01-482-9393 RQST NE Related Documents 6515-01-482-9393 1+ Documents ( More...
Restrictions 6515-01-482-9393
6515-01-482-9393 is a Cornea Collagen Shield that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item is not suspected to be hazardous. This item does not contain a precious metal.
End Users 6515-01-482-9393
- United Kingdom (ZK01)
- Effective Date:
- 1 Mar 2001
Approved Sources 6515-01-482-9393
- Part Number
- Manufacturer
- Status
- 7012
- Manufacturer
- 0UBP5 - Oasis Medical, Inc. (Active)
- Primary Buy
- Primary Buy
Datasheet 6515-01-482-9393
- Characteristic
- Specifications
- FIIG
- Specifications
- A23900
- General Characteristics Item Description [TEXT]
- Aids In Post-Op Management To Obtain A Quiet Eye; Thin, Purified, Bovine Collagen Shield; 14.5Mm Dia.; Compound Base Curve; When Applied To Eye It Absorbs Ocular Fluids And Begins To Dissolve And Conform To Eye; Dissolution Rate 12 Hrs.
- Part Name Assigned By Controlling Agency [CXCY]
- Soft Shield
Similar Supply Items to 6515-01-482-9393
Freight Information 6515-01-482-9393
6515-01-482-9393 has freight characteristics.. 6515-01-482-9393 has a variance between NMFC and UFC when transported by rail and the description should be consulted.